Announcements Trials
Browse Landscape

Phase

Phase 3 13Phase 2 13Phase 4 5Phase NA 3Phase 1/2 2Phase 2/3 1Phase 1 1

Status

Completed 5Not yet recruiting 1

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 5

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Vomiting 5Neoplasms 4Nausea 3Lymphoma 1Leukemia 1

Interventions

Zoledronic Acid 28Saline Solution 26Metformin 25Dexamethasone 25Cyclophosphamide 23Cytarabine 22Bupivacaine 20Sodium Chloride 18Vincristine 17Methotrexate 17Letrozole 17Propofol 15Morphine 15Doxorubicin 15Cisplatin 15Prednisolone 14Docetaxel 14Dexmedetomidine 14Bevacizumab 14Oxycodone 13Imiquimod 13Fentanyl 13Capecitabine 13Rituximab 12Mercaptopurine 12Fluorouracil 12Granulocyte Colony-Stimulating Factor 11Everolimus 11Asparaginase 11Acetaminophen 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 4 × Completed × Palonosetron × Clear all
NCT02532634 2018-05-11

RAPA

Kangdong Sacred Heart Hospital

Phase 4 Completed
292 enrolled

Neoplasms, Vomiting

NCT00684463 2017-05-16

Palonosetron in Moderately and Highly Emetogenic Chemotherapy Induced Nausea and Vomiting (Study P04935)(COMPLETED)

Merck Sharp & Dohme LLC

Phase 4 Completed
59 enrolled

Nausea, Neoplasms, Vomiting

NCT00687011 2017-05-15

Palonosetron Plus Dexamethasone in Moderately Emetogenic Chemotherapy Induced Nausea and Vomiting (Study P04594)

Merck Sharp & Dohme LLC

Phase 4 Completed
118 enrolled

Nausea, Neoplasms, Vomiting

NCT01481831 2012-12-31

ESPNV

Shanghai Changzheng Hospital

Phase 4 Completed
599 enrolled

Neoplasms, Vomiting

NCT00415103 2009-09-18

AMENO-2

PETHEMA Foundation

Phase 4 Completed
196 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡